Astrelis
Dialysis facility · MD

DIALYSIS 212595

CCN 212595Latest FY 2021
Historical record. CMS lists this CCN as terminated (voluntary - merger/closure). No successor CCN is recorded. The financials below are the historical results reported under this number and are excluded from current peer comparisons and state counts.
Cost-report basis
HCRIS · as filed
Not audited by Astrelis

Operating margin: +2.2% in FY2021. Total operating revenue: $3.1M in FY2021. Total margin (including nonoperating): +2.2% in FY2021. Figures as filed; not audited by Astrelis.

The read

A dialysis facility in MD. It ran an operating surplus of 2.2% in FY21 on $3.1M of operating revenue. Operating margin improved from -0.2% in FY20 to 2.2% in FY21.

Operating margin · FY21
+2.2%
Astrelis calculation · as-filed inputs
▲ 2.4 pts vs FY20
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY21)
Days cash on hand
Astrelis calculation unavailable
Total operating revenue · FY21
$3.1M
Astrelis calculation · as-filed inputs
▼ $0.1M vs FY20
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY21)
Total margin · incl. nonoperating · FY21
+2.2%
Astrelis calculation · as-filed inputs
▲ 2.4 pts vs FY20
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY21)

The money

$ thousands · HCRIS cost-report basis · as filed, QA-gated

Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.

Operating margin
+2.2% (FY21)
Operating income ÷ total operating revenue
Astrelis calculation · HCRIS WS G-3
Total margin
+2.2% (FY21)
Net income ÷ total revenue incl. nonoperating
Astrelis calculation · HCRIS WS G-3
Days cash on hand
Not reported in source
Cash & investments ÷ daily operating expense
Astrelis calculation · HCRIS WS G / G-3
Current ratio
38.65× (FY21) — outside expected range; computed from the filed statement and not ranked against peers
Total current assets ÷ current liabilities
Astrelis calculation · HCRIS WS G
Equity financing ratio
78% (FY21)
Total net assets ÷ total assets
Astrelis calculation · HCRIS WS G
Days in net patient A/R
56d (FY21)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
Astrelis calculation · HCRIS WS G / G-3
$ in thousands
Line itemFY20FY21
Patient revenue3,1703,061
Total operating revenue3,1703,061
Total operating expenses3,1752,993
Operating income(5)68
Operating margin %-0.2%+2.2%
Net income(5)68
Net income %-0.2%+2.2%
2 of 3 years available for this statement.
— = Not reported in source for that year.
HCRIS CMS-265 cost report · $ thousands · FY20–FY21 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding

How it operates

quality & operational context · CMS public reporting

The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by provenance class and public source; descriptive context only, never a ranking or adequacy claim. Provenance labels: Reported value is copied from the named public source; Astrelis calculation is a formula applied to unchanged reported inputs, with the formula shown; Illustrative estimate is a benchmark gap, multiplier, or scenario — never a measurement.

Total treatments
10,068
Reported value2021
HCRIS CMS-265
Cost per treatment ($)
297.27
Astrelis calculation2021
HCRIS CMS-265
Net revenue per treatment ($)
304.02
Astrelis calculation2021
HCRIS CMS-265

Trajectory

Cost-report basis · 2 reporting years
Operating margin
-0.2%+2.2%FY20FY21
Days cash on hand
Not available

State context

Maryland
County-level statistics: linkage not established — this record's county mapping is not verified in the resolved spine, and we never place a facility in a county by guesswork. State-level context appears here once a state aggregate layer lands.
Operating margin (as filed)FY21Astrelis calculation

2.2% operating margin in FY21.

The Board Briefing

Operating margin improved 2.4 points vs FY20 — the briefing traces why, line by line.

Reserve The Board Briefing →
Report coverage: Historical Facility Benchmark. 6 of 10 facility measures available from public sources. This CCN is terminated. The report benchmarks the record's final filed years against their own contemporaneous peer pools and says so on every exhibit; no current-year comparison is implied. The refund guarantee stands: if we cannot deliver the published scope, you pay nothing.

Portfolio Performance Review

A roster-priced triage of the per-facility benchmarks: every facility on your roster, benchmarked and sorted. Requires only a CCN roster.

From $7,500Founding Edition · built to order, first edition · priced by roster size · invoice after coverage confirmation · within 30 days
Request: scoped and quoted before any invoice. No payment is collected on this site.

Cite this page

release 2321a4fc37a7 · 2026-10-22

Astrelis Atlas, "Dialysis 212595", https://astrelis.co/providers/dialysis/212595, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Machine-readable twin of this page: astrelis.co/providers/dialysis/212595.md (Markdown, the same figures with their fiscal years, pools and definitions). Last modified: release 2321a4fc37a7, 2026-10-22. Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.

build 2321a4fc37a7 · 2026-10-22 · dev